Doyle Mittie bought AVTX

March 16, 2026 · Form 4 insider transaction

Doyle Mittie bought 5,992 shares of Avalo Therapeutics, Inc. at $8.04 per share, a transaction worth $48.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.